194,840 Shares in Oscar Health, Inc. (NYSE:OSCR) Bought by DnB Asset Management AS

DnB Asset Management AS bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 194,840 shares of the company’s stock, valued at approximately $2,619,000. DnB Asset Management AS owned about 0.08% of Oscar Health at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of OSCR. Norges Bank bought a new position in Oscar Health in the fourth quarter worth about $1,085,000. BIT Capital GmbH raised its position in shares of Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock worth $60,129,000 after purchasing an additional 4,396,872 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after purchasing an additional 8,051,379 shares during the last quarter. Potentia Wealth acquired a new position in Oscar Health during the 4th quarter valued at approximately $141,000. Finally, Vanguard Group Inc. grew its stake in Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company’s stock worth $255,333,000 after buying an additional 586,626 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on OSCR shares. Jefferies Financial Group began coverage on Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Oscar Health presently has an average rating of “Hold” and an average target price of $20.21.

Oscar Health Stock Down 1.1 %

Oscar Health stock opened at $12.97 on Wednesday. The company’s 50-day moving average price is $14.79 and its two-hundred day moving average price is $15.94. The stock has a market cap of $3.25 billion, a price-to-earnings ratio of -648.28 and a beta of 1.75. Oscar Health, Inc. has a 52 week low of $12.43 and a 52 week high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.